Addition of bisphosphonate therapy with etidronate or alendronate to stable estrogen replacement therapy in postmenopausal women increases lumbar spine and femoral trochanter bone mineral density.

被引：0
|
作者：
Sebaldt, RJ [1 ]
Adachi, JD [1 ]
Gordon, M [1 ]
Petrie, A [1 ]
Goldsmith, CH [1 ]
机构：
[1] McMaster Univ, St Josephs Hosp, CANDOO Project, Hamilton, ON L8N 4A6, Canada
来源：
ARTHRITIS AND RHEUMATISM | 1998年 / 41卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
68
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [21] The effect of strength training combined with bisphosphonate (etidronate) therapy on bone mineral, lean tissue, and fat mass in postmenopausal women
    Chilibeck, PD
    Davison, KS
    Whiting, SJ
    Suzuki, Y
    Janzen, CL
    Peloso, P
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2002, 80 (10) : 941 - 950
  • [22] Interaction between hormone replacement therapy and resistance training on spine bone mineral density in early postmenopausal women.
    Maddalozzo, GF
    Widrick, JJ
    Hoffman, MA
    Snow, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S384 - S384
  • [23] Effects of hormone replacement therapy alone or in combination with alendronate on bone mineral density of women with osteoporosis
    Karzewnik, Ewa
    Sewerynek, Ewa
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2005, 4 (06): : 10 - 16
  • [24] Estrogen receptors polymorphisms: Relation with bone mineral density and lipid profile and response to hormone replacement therapy in postmenopausal women
    Silvestri, S
    Thomsen, AB
    Gozzini, A
    Bagger, Y
    Christiansen, C
    Brandi, M
    BONE, 2005, 36 : S250 - S250
  • [25] COMPARISON OF THE EFFECT OF DENOSUMAB ON BONE MINERAL DENSITY OF LUMBAR SPINE AND FEMORAL NECK IN POSTEMENOPAUSAL WOMEN WITH OSTEOPOROSIS, WHEN ADMINISTERED AS FIRST-LINE THERAPY OR AFTER BISPHOSPHONATE
    Mole, E.
    Alexoudis, A.
    Moshou, D.
    Zoupidou, K.
    Konstantinou, E.
    Gazi, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (01) : S48 - S48
  • [26] Does continued alendronate therapy improve bone mineral density and reduce fracture risk in postmenopausal women?
    Kraenzlin, Marius E.
    Meier, Christian
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (10): : 686 - 687
  • [27] Does continued alendronate therapy improve bone mineral density and reduce fracture risk in postmenopausal women?
    Marius E Kraenzlin
    Christian Meier
    Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 : 686 - 687
  • [28] Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis
    Hochberg, MC
    Ross, PD
    Black, D
    Cummings, SR
    Genant, HK
    Nevitt, MC
    Barret-Connor, E
    Musliner, T
    Thompson, D
    ARTHRITIS AND RHEUMATISM, 1999, 42 (06): : 1246 - 1254
  • [29] Clinical features affecting the results of estrogen replacement therapy on bone density in Japanese postmenopausal women
    Morishige, K
    Matsumoto, K
    Ohmichi, M
    Nishio, Y
    Adachi, K
    Hayakawa, J
    Nukui, K
    Tasaka, K
    Kurachi, H
    Murata, Y
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2001, 52 (04) : 223 - 226
  • [30] Influence of bisphosphonate therapy on bone geometry, volumetric bone density and bone strength of femoral shaft in postmenopausal women with rheumatoid arthritis
    Rahel Meinen
    Inna Galli-Lysak
    Peter M. Villiger
    Daniel Aeberli
    BMC Musculoskeletal Disorders, 17
12345